Signalling Pathways and Inhibitors in Triple Negative Breast Cancer: Current Progress
{{output}}
Introduction: Triple Negative Breast Cancer (TNBC), which makes up 15% of all breast cancers, is widely acknowledged as the most aggressive and challenging subtype of the disease. It is characterized by the absence of HER2 recept... ...